Last updated: 11/07/2018 18:31:10
A Multicenter Study to Evaluate the Efficacy and Safety of a Repeat Dose of Ondansetron in Ambulatory Surgery Patients who do not Achieve Adequate Control of Postoperative Nausea and Vomiting Following Prophylaxis With Open-Label Intravenous Ondansetron
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Multicenter Study to Evaluate the Efficacy and Safety of a Repeat Dose of Ondansetron in Ambulatory Surgery Patients who do not Achieve Adequate Control of Postoperative Nausea and Vomiting Following Prophylaxis With Open-Label Intravenous Ondansetron
Trial description: A Multicenter Study to Evaluate the Efficacy and Safety of a Repeat Dose of Ondansetron in Ambulatory Surgery Patients who do not Achieve Adequate Control of Postoperative Nausea and Vomiting Following Prophylaxis With Open-Label Intravenous Ondansetron
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Kovac AL, O’Connor TA, Pearman MH, Kekoler LJ, Edmondson D, Baughman VL, Angel JJ, Campbell C, Jense HG, Mingus ML, Shahvari MBG, Creed MR. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicenter trial. Journal of Clinical Anesthesia 1999; 11(6):453-459.
Medical condition
Nausea and Vomiting, Postoperative
Product
ondansetron
Collaborators
Not applicable
Study date(s)
May 1994 to August 1995
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1995-08-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website